share_log

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT：其他
美股SEC公告 ·  07/30 18:06

Moomoo AI 已提取核心信息

T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.
T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.
T2 Biosystems公司是一家在美国上市的公司，于2024年7月29日下午4:00获得了美国证券交易委员会（SEC）的有效公告。该公告涉及S-3表格，这通常是公司为潜在的未来发行注册证券所使用的表格。该表格的有效性表明SEC已经审查并接受了公司的注册声明，允许T2 Biosystems按照文件中概述的方式发行证券。该公司的CIK号码为0001492674，与此公告相关联的文件编号为333-280922。
T2 Biosystems公司是一家在美国上市的公司，于2024年7月29日下午4:00获得了美国证券交易委员会（SEC）的有效公告。该公告涉及S-3表格，这通常是公司为潜在的未来发行注册证券所使用的表格。该表格的有效性表明SEC已经审查并接受了公司的注册声明，允许T2 Biosystems按照文件中概述的方式发行证券。该公司的CIK号码为0001492674，与此公告相关联的文件编号为333-280922。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间